MedTrace Logo

Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures

NCT01639534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-07-31

No results posted yet for this study

Summary

The purpose of the study is to determine if a new blood test can help the doctor determine if there is brain injury or ischemia. Ischemia occurs when not enough oxygen gets to the brain. In this study the investigators are analyzing your blood for a new test that might help doctors decide if symptoms are from a neurologic problem.

Conditions

  • Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood
  • Ischemia/Hypoperfusion of Brain

Sponsors & Collaborators

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Lynne Gehr, MD · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-10-09
Completion
2013-10-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639534 on ClinicalTrials.gov